You are here

Efficacy and Safety of Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia

Last updated on February 17, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
La Plata, Buenos Aires, (1900) Argentina
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Schizophrenia
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-50 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Diagnosis of schizophrenia (according to Diagnostic and Statistical Manual of Mental
Disorders [DSM]-IV-TR criteria and made by a specialist in psychiatry) and acute
exacerbation of schizophrenia requiring hospitalization

- Total PANSS score of ?60 at screening

- History of schizophrenia of ?10 years (from onset of prodromal symptoms)

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Axis-I DSM-IV-TR diagnosis other than schizophrenia

- Less than a full cycle has lapsed at time of screening following the last injection of
a depot antipsychotic

- Currently taking celecoxib or other selective cyclo-oxygenase 2 inhibitors, or other
antiinflammatory medication

NCT00639483
Pfizer
Completed
Efficacy and Safety of Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Schizophrenia
NCT00239109
All Genders
18+
Years
Multiple Sites
Schizophrenia
NCT00136994
All Genders
18+
Years
Multiple Sites
Schizophrenia
NCT00418171
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now